Reversing the standard approved dose levels of nivolumab (Opdivo) and ipilimumab (Yervoy) in metastatic melanoma led to less ...
Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...
The study assessed the overall diagnostic accuracy of the Merlin CP-GEP Test for predicting sentinel node metastases and recurrence riskThe Merlin CP-GEP Test demonstrated strong predictive ...
MedPage Today on MSN
PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma
First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...
CHICAGO — Two new drugs have been found to prolong the lives of people with advanced melanoma, representing what researchers say is notable progress against the deadly skin cancer after decades of ...
The "ugly duckling" sign, a dermatological clue, identifies moles that stand out from others in size, shape, color, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback